{"brief_title": "Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4", "brief_summary": "The purpose of this study is to empirically test a series of medications to: 1) determine each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective dose range for each medication. In this study, amantadine is tested.\"", "detailed_description": "16-week participation plus a 2 weekk lead-in period. Participants are assigned randomly to placebo or amantadine. Participants attend group meeting 3 times/week", "condition": ["Cocaine-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Amantadine"], "criteria": "Inclusion Criteria: M/F, ages 18-65. cocaine dependence according to DMS-IV criteria. Self-reported use within the last 30 days. Agreeable to conditions of the study and signed informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy, history of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "keyword": "Outpatient", "mesh_term": ["Cocaine-Related Disorders", "Amantadine", "Cocaine"], "id": "NCT00000301"}